A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1

Documenti analoghi

• Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia
  di: Patkar, Nikhil, et al.
  Pubblicazione: (2018)
• Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia
  di: Patkar, Nikhil, et al.
  Pubblicazione: (2019)
• Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context
  di: Patkar, Nikhil, et al.
  Pubblicazione: (2019)
• Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1
  di: Shaikh, Anam Fatima, et al.
  Pubblicazione: (2020)
• Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
  di: Patkar, Nikhil, et al.
  Pubblicazione: (2021)